Meads, Mark B.

Environment-mediated drug resistance: A major contributor to minimal residual disease

Meads, M. B., Gatenby, R. A., & Dalton, W. S. (2009) · Nature Reviews Cancer

Cancer Cells and MetastasisAcute Lymphoblastic Leukemia research

Cited by 892

Plasma cell dependence on histone/protein deacetylase 11 reveals a therapeutic target in multiple myeloma

Mostofa, A., Distler, A., Meads, M. B., Sahakian, E., Powers, J. J., Achille, A., Noyes, D., Wright, G., Fang, B., Izumi, V., et al. (2021) · JCI Insight

Multiple Myeloma Research and TreatmentsHistone Deacetylase Inhibitors Research

Cited by 27